Skip to main content
. 2022 Mar 8;14(3):592. doi: 10.3390/pharmaceutics14030592

Figure 2.

Figure 2

Distribution of severity levels of pDDIs in patients with MS. For the 627 patients, we recorded 2887 pDDIs in total (counted with repetitions) based on MediQ and Stockley’s drug interaction checker. MS—multiple sclerosis; pDDI—potential drug–drug interaction.